首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

2055121

核子醫學軟體市場：按類型、模式、治療領域、部署模式、整合複雜性、定價模式、最終用戶和地區分類

Nuclear Medicine Software Market, By Type, By Modality, By Therapeutic Area, By Deployment Model, By Integration Complexity, By Pricing Model, By End User, By Geography

出版日期: 2026年03月10日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，核醫軟體市場規模將達到 10.717 億美元，到 2033 年將達到 19.971 億美元。預計從 2026 年到 2033 年，該市場將以 9.3% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1,071,700,000 美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.30%	2033年市場規模預測：	19.971億美元

全球核子醫學軟體市場是支撐核子醫學和分子影像領域快速發展的關鍵技術基礎。這類專業軟體涵蓋了旨在促進核醫影像資料（包括SPECT、PET和混合影像模式）採集、處理、分析和管理的綜合解決方案。

核子醫學軟體在提高全球醫療機構的診斷準確性、簡化工作流程和支援臨床決策方面發揮著至關重要的作用。該市場涵蓋多種軟體類別，例如影像重建軟體、定量分析工具、報告系統和整合醫院資訊管理平台。

隨著醫療系統對精準醫療和個人化治療的日益重視，核醫學軟體已成為支持先進分子成像技術和放射性藥物應用的基礎要素。人工智慧、機器學習演算法和雲端平台的整合正在革新傳統的核醫學實踐，從而顯著提升影像品質、實現自動化分析並增強病患診療流程。

市場動態

全球核醫軟體市場受多種強勁因素驅動，這些因素共同支撐著其穩健的成長動能。慢性疾病（尤其是癌症和心血管疾病）的日益普遍是推動市場擴張的主要催化劑。這是因為醫療機構需要先進的診斷解決方案來改善患者預後並制定治療方案。混合成像技術（包括PET/CT和SPECT/CT系統）的日益普及，需要能夠處理複雜多模態資料整合和分析的先進軟體平台，這進一步推動了對綜合核醫學軟體解決方案的需求。

人工智慧 (AI) 和機器學習技術的進步顯著提升了軟體功能，實現了影像自動分析，提高了診斷準確率，並縮短了影像解讀時間。這吸引了許多追求營運效率和卓越臨床水準的醫療機構的注意。然而，市場也存在著許多限制因素。其中之一是先進核醫軟體系統的高昂實施成本，這對預算有限的醫療機構無疑是一筆沉重的負擔。在新興市場，成本意識尤其重要，因此這一趨勢更為突出。此外，軟體與現有醫院資訊系統整合以及監管合規要求的複雜性也會為實施帶來挑戰，可能導致部署進度延誤和營運成本增加。

熟練核醫技術並能有效利用先進軟體平台的專業人員短缺，也是限制市場成長的因素之一。培訓和專業知識不足會限制軟體的普及和投資回報。儘管面臨這些挑戰，但隨著核子醫學在精準醫療和治療診斷學的應用不斷擴展，也湧現出巨大的機會。在這些領域，軟體平台可以支援個人化治療方案和放射性藥物治療的監測。隨著人們越來越關注以價值為導向的醫療服務模式，軟體供應商有機會開發出能夠顯著提升診斷效率、病患處理能力和臨床療效的解決方案。這將證明投資的合理性，並加速軟體在各種醫療環境中的市場滲透。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數介紹了全球核醫學軟體市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球核子醫學軟體市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過分析全球核子醫學軟體市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第12章競爭格局

Siemens Healthineers
GE HealthCare
Philips Healthcare
Canon Medical Systems Corporation
Bracco Imaging SpA（via Advanced Accelerator Applications）
Hermes Medical Solutions AB
Segami Corporation
MIM Software Inc.
Mirada Medical Ltd.
INVIA Medical Imaging Solutions
Mediso Medical Imaging Systems
Nuclear Diagnostics AB
Sofie Biosciences Inc.
PMOD Technologies LLC
Xeleris

第13章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第14章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8470

Nuclear Medicine Software Market is estimated to be valued at USD 1071.7 Mn in 2026 and is expected to reach USD 1,997.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1071.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.30%	2033 Value Projection:	USD 1,997.1 Mn

The global nuclear medicine software market represents a critical technological backbone supporting the rapidly evolving field of nuclear medicine and molecular imaging. This specialized software encompasses comprehensive solutions designed to facilitate the acquisition, processing, analysis, and management of nuclear medical imaging data, including SPECT, PET, and hybrid imaging modalities.

Nuclear medicine software plays an indispensable role in enhancing diagnostic accuracy, streamlining workflow efficiency, and supporting clinical decision-making across healthcare institutions worldwide. The market encompasses various software categories including image reconstruction software, quantitative analysis tools, reporting systems, and integrated hospital information management platforms.

As healthcare systems increasingly prioritize precision medicine and personalized treatment approaches, nuclear medicine software has emerged as a fundamental component enabling advanced molecular imaging techniques and radiopharmaceutical applications. The integration of artificial intelligence, machine learning algorithms, and cloud-based platforms has revolutionized traditional nuclear medicine practices, offering enhanced image quality, automated analysis capabilities, and improved patient throughput.

Market Dynamics

The global nuclear medicine software market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the increasing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, serving as a primary catalyst for market expansion as healthcare providers seek advanced diagnostic solutions to improve patient outcomes and treatment planning. The growing adoption of hybrid imaging technologies, including PET/CT and SPECT/CT systems, necessitates sophisticated software platforms capable of handling complex multi-modal data integration and analysis, thereby driving demand for comprehensive nuclear medicine software solutions.

Technological advancements in artificial intelligence and machine learning are significantly enhancing software capabilities, enabling automated image analysis, improved diagnostic accuracy, and reduced interpretation time, which attracts healthcare institutions seeking operational efficiency and clinical excellence. However, the market faces notable restraints including substantial implementation costs associated with advanced nuclear medicine software systems, which can burden healthcare facilities with limited budgets, particularly in emerging markets where cost-sensitivity remains a critical consideration. Additionally, the complexity of software integration with existing hospital information systems and regulatory compliance requirements create implementation challenges that may delay adoption timelines and increase operational overhead.

The shortage of skilled nuclear medicine professionals capable of effectively utilizing advanced software platforms also constrains market growth, as inadequate training and expertise can limit software utilization and return on investment. Despite these challenges, significant opportunities emerge through the expanding applications of nuclear medicine in precision medicine and theranostics, where software platforms can support personalized treatment approaches and radiopharmaceutical therapy monitoring. The increasing focus on value-based healthcare delivery models creates opportunities for software vendors to develop solutions that demonstrate measurable improvements in diagnostic efficiency, patient throughput, and clinical outcomes, thereby justifying investment costs and driving market penetration across diverse healthcare settings.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nuclear medicine software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Bracco Imaging S.p.A. (via Advanced Accelerator Applications), Hermes Medical Solutions AB, Segami Corporation, MIM Software Inc., Mirada Medical Ltd., INVIA Medical Imaging Solutions, Mediso Medical Imaging Systems, Nuclear Diagnostics AB, Sofie Biosciences Inc., PMOD Technologies LLC, and Xeleris
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nuclear medicine software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine software market

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
Patient Data Management Software
Imaging and Visualization Software
Analysis and Quantification Software
Clinical Decision Support Software
Dosimetry Software
Workflow and Scheduling Software
Treatment Planning Software
Others (Artificial Intelligence (AI) and Analytics Software, etc.)
Modality Insights (Revenue, USD Mn, 2021 - 2033)
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
Others (Planar Scintigraphy, hybrid systems)
Therapeutic Area Insights (Revenue, USD Mn, 2021 - 2033)
Oncology
Cardiology
Neurology
Endocrinology
Gastroenterology
Others (Orthopedics, Infectious disease imaging, etc.)
Deployment Model Insights (Revenue, USD Mn, 2021 - 2033)
On-Premise
Cloud-Based
Integration Complexity Insights (Revenue, USD Mn, 2021 - 2033)
Standalone Software
Integrated Software Solutions
Pricing Model Insights (Revenue, USD Mn, 2021 - 2033)
Subscription-based Pricing
Perpetual License Pricing
Usage-based Pricing (pay-per-use)
Freemium or Trial-based Pricing
Customized or Enterprise Pricing
End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals and Clinics
Diagnostic Imaging Centers
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Siemens Healthineers
GE HealthCare
Philips Healthcare
Canon Medical Systems Corporation
Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
Hermes Medical Solutions AB
Segami Corporation
MIM Software Inc.
Mirada Medical Ltd.
INVIA Medical Imaging Solutions
Mediso Medical Imaging Systems
Nuclear Diagnostics AB
Sofie Biosciences Inc.
PMOD Technologies LLC
Xeleris

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Nuclear Medicine Software Market, By Type
- Global Nuclear Medicine Software Market, By Modality
- Global Nuclear Medicine Software Market, By Therapeutic Area
- Global Nuclear Medicine Software Market, By Deployment Model
- Global Nuclear Medicine Software Market, By Integration Complexity
- Global Nuclear Medicine Software Market, By Pricing Model
- Global Nuclear Medicine Software Market, By End User
- Global Nuclear Medicine Software Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Nuclear Medicine Software Market, By Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Patient Data Management Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Imaging and Visualization Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Analysis and Quantification Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Clinical Decision Support Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Dosimetry Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Workflow and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Treatment Planning Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Nuclear Medicine Software Market, By Modality, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others (Planar Scintigraphy, hybrid systems)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Nuclear Medicine Software Market, By Therapeutic Area, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others (Orthopedics, Infectious disease imaging, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Nuclear Medicine Software Market, By Deployment Model, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Nuclear Medicine Software Market, By Integration Complexity, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Standalone Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Integrated Software Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

9. Global Nuclear Medicine Software Market, By Pricing Model, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Subscription-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Perpetual License Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Usage-based Pricing (pay-per-use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Freemium or Trial-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Customized or Enterprise Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

10. Global Nuclear Medicine Software Market, By End User, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

11. Global Nuclear Medicine Software Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hermes Medical Solutions AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Segami Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MIM Software Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mirada Medical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
INVIA Medical Imaging Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mediso Medical Imaging Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nuclear Diagnostics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sofie Biosciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PMOD Technologies LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Xeleris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies